Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudia Baratè

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Blood Reviews|February 10, 2007
CryoglobulinemiaAlessandra Tedeschi, Claudia Baratè, Ernesto Minola, et al.
Frontiers in Oncology|December 3, 2019
Mechanisms Underlying the Anti-inflammatory and Immunosuppressive Activity of RuxolitinibElena Maria Elli, Claudia Baratè, Francesco Mendicino, et al.
Hematological Oncology|December 14, 2019
Myeloproliferative and lymphoproliferative disorders: State of the artElisa Rumi, Claudia Baratè, Giulia Benevolo, et al.
Frontiers in Oncology|September 27, 2019
Monitoring Chronic Myeloid Leukemia: How Molecular Tools May Drive Therapeutic ApproachesBarbara Izzo, Enrico Marco Gottardi, Santa Errichiello, et al.
International Journal of Molecular Sciences|September 25, 2015
Pharmacogenetics of BCR/ABL Inhibitors in Chronic Myeloid LeukemiaMarialuisa Polillo, Sara Galimberti, Claudia Baratè, et al.
American Journal of Hematology|August 19, 2011
High-dose (40,000 IU twice/week) alpha recombinant human erythropoietin as single agent in low/intermediate risk myelodysplastic syndromes: a retrospective investigation on 133 patients treated in a single institutionAntonio Azzarà, Giovanni Carulli, Sara Galimberti, et al.
Leukemia Research|February 13, 2010
Abnormal phenotype of bone marrow plasma cells in patients with chronic myeloid leukemia undergoing therapy with ImatinibGiovanni Carulli, Elisa Cannizzo, Virginia Ottaviano, et al.
Clinical and Experimental Medicine|September 8, 2022
Induction of neutralizing antibodies in CLL patients after SARS-CoV-2 mRNA vaccination: a monocentric experienceClaudia Baratè, Teresita Caruso, Fabrizio Mavilia, et al.
Frontiers in Oncology|September 25, 2024
Management of infections for patient treated with ibrutinib in clinical practiceClaudia Baratè, Ilaria Scortechini, Sara Ciofini, et al.
Leukemia Research and Treatment|December 1, 2012
Identification of a novel p190-derived breakpoint Peptide suitable for Peptide vaccine therapeutic approach in ph+ acute lymphoblastic leukemia patientsMicaela Ippoliti, Marzia Defina, Antonella Gozzini, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Blood Reviews|February 10, 2007
CryoglobulinemiaAlessandra Tedeschi, Claudia Baratè, Ernesto Minola, et al.
Frontiers in Oncology|December 3, 2019
Mechanisms Underlying the Anti-inflammatory and Immunosuppressive Activity of RuxolitinibElena Maria Elli, Claudia Baratè, Francesco Mendicino, et al.
Hematological Oncology|December 14, 2019
Myeloproliferative and lymphoproliferative disorders: State of the artElisa Rumi, Claudia Baratè, Giulia Benevolo, et al.
Frontiers in Oncology|September 27, 2019
Monitoring Chronic Myeloid Leukemia: How Molecular Tools May Drive Therapeutic ApproachesBarbara Izzo, Enrico Marco Gottardi, Santa Errichiello, et al.
International Journal of Molecular Sciences|September 25, 2015
Pharmacogenetics of BCR/ABL Inhibitors in Chronic Myeloid LeukemiaMarialuisa Polillo, Sara Galimberti, Claudia Baratè, et al.
American Journal of Hematology|August 19, 2011
High-dose (40,000 IU twice/week) alpha recombinant human erythropoietin as single agent in low/intermediate risk myelodysplastic syndromes: a retrospective investigation on 133 patients treated in a single institutionAntonio Azzarà, Giovanni Carulli, Sara Galimberti, et al.
Leukemia Research|February 13, 2010
Abnormal phenotype of bone marrow plasma cells in patients with chronic myeloid leukemia undergoing therapy with ImatinibGiovanni Carulli, Elisa Cannizzo, Virginia Ottaviano, et al.
Clinical and Experimental Medicine|September 8, 2022
Induction of neutralizing antibodies in CLL patients after SARS-CoV-2 mRNA vaccination: a monocentric experienceClaudia Baratè, Teresita Caruso, Fabrizio Mavilia, et al.
Frontiers in Oncology|September 25, 2024
Management of infections for patient treated with ibrutinib in clinical practiceClaudia Baratè, Ilaria Scortechini, Sara Ciofini, et al.
Leukemia Research and Treatment|December 1, 2012
Identification of a novel p190-derived breakpoint Peptide suitable for Peptide vaccine therapeutic approach in ph+ acute lymphoblastic leukemia patientsMicaela Ippoliti, Marzia Defina, Antonella Gozzini, et al.
Pageof 6